Announce Date | 05/07/2025 |
EPS Normalized Actual | $1.77 (Beat by $0.09) |
EPS GAAP Actual | $1.77 (Beat by $0.09) |
Revenue Actual | $1.194B |
Revenue Surprise | Beat by $1194M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.41653 |
EPS GAAP Estimate | $3.41653 |
Revenue Estimate | $1.43255B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.15 | 3.25 | 8.21669 | 9.95121 | 1 |
Dec 2028 | 11.94 | 2.49 | 10.96228 | 13.10433 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.99 | 1.99 | 1.194B | -11.32% | 1194M |
FQ4 2024 (Dec 2024) | 1.53 | 1.53 | 1.29175B | 12.77% | 1291.75M |
FQ3 2024 (Sep 2024) | 3.02 | 3.02 | 1.27205B | 18.56% | 1272.05M |
FQ4 2012 (Dec 2012) | 34.52 | 34.52 | 0.0735919B | 100% | 73.59M |
FQ4 2013 (Dec 2013) | 70.32 | 70.32 | 0.133062B | 44.69% | 133.06M |
FQ4 2014 (Dec 2014) | -114.97 | -114.97 | 0.123185B | -8.02% | 123.19M |
FQ4 2015 (Dec 2015) | -1311.73 | -1311.73 | 0.057032B | -115.99% | 57.03M |
FQ2 2024 (Jun 2024) | 2.17 | 2.17 | 1.31269B | 100% | 1312.69M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
3.41653
Consensus Revenue Estimates
1.43255B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 4 |
FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 3 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 2 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 2 |
FQ4 2026 (Oct 2026) | 3.05103 | -- | 2.80207 | 3.34261 | 3 |
FQ3 2026 (Jul 2026) | 3.00573 | -- | 2.76047 | 3.29298 | 3 |
FQ2 2026 (Jun 2026) | 3.07851 | -- | 2.91349 | 3.27225 | 3 |
FQ1 2026 (Mar 2026) | 3.25224 | 38.81 | 3.0779 | 3.45691 | 3 |
FQ4 2025 (Oct 2025) | 3.46291 | 55.82 | 3.18034 | 3.79385 | 4 |
FQ3 2025 (Sep 2025) | 3.41653 | 11.61 | 3.23339 | 3.63154 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.19B | -- | 1.11B | 1.28B | 4 |
FQ3 2027 (Jul 2027) | 1.17B | -- | 1.1B | 1.26B | 6 |
FQ2 2027 (Jun 2027) | 1.17B | -- | 1.13B | 1.23B | 3 |
FQ1 2027 (Mar 2027) | 1.18B | -- | 1.13B | 1.23B | 3 |
FQ4 2026 (Oct 2026) | 1.36B | -- | 1.28B | 1.46B | 4 |
FQ3 2026 (Jul 2026) | 1.36B | -- | 1.27B | 1.46B | 6 |
FQ2 2026 (Jun 2026) | 1.37B | -- | 1.32B | 1.44B | 4 |
FQ1 2026 (Mar 2026) | 1.37B | 12.72 | 1.31B | 1.43B | 4 |
FQ4 2025 (Oct 2025) | 1.42B | 9.27 | 1.33B | 1.53B | 3 |
FQ3 2025 (Sep 2025) | 1.43B | 11.2 | 1.37B | 1.5B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.99 | 1.99 | 100% | |
FQ4 2024 (Dec 2024) | 1.53 | 1.53 | 100% | |
FQ3 2024 (Sep 2024) | 3.02 | 3.02 | 100% | |
FQ4 2012 (Dec 2012) | 34.52 | 34.52 | 100% | |
FQ4 2013 (Dec 2013) | 70.32 | 70.32 | 100% | |
FQ4 2014 (Dec 2014) | -114.97 | -114.97 | 100% | |
FQ4 2015 (Dec 2015) | -1311.73 | -1311.73 | 100% | |
FQ2 2024 (Jun 2024) | 2.17 | 2.17 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.19B | $1194M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.29B | $1291.75M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.27B | $1272.05M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.07B | $73.59M | 100% |
FQ4 2013 (Dec 2013) | $0B | $0.13B | $133.06M | 100% |
FQ4 2014 (Dec 2014) | $0B | $0.12B | $123.19M | 100% |
FQ4 2015 (Dec 2015) | $0B | $0.06B | $57.03M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.31B | $1312.69M | 100% |